The Lilac Device for Peripheral Neuropathy
(IMPACT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Chemotherapy drugs, used in the treatment of cancer, have the potential of inducing peripheral neuropathy (PN) as a side effect. This side effect is commonly referred to as CIPN, or chemotherapy-induced peripheral neuropathy.
The Lilac Glove and Boot devices apply a low pressure across the surface of the hands and feet, respectively, to reduce access of chemotherapy to the peripheral nerves on the hands and feet. The small amount of pressure reduces the level of chemotherapy reaching the peripheral nerves, hence increasing the likelihood of nerve preservation during treatment and thus may potentially temporarily prevent the onset of moderate to severe PN symptoms induced by chemotherapy in the hands and feet while receiving treatment
Are You a Good Fit for This Trial?
Adults over 18 with solid tumor cancer set for at least 4 cycles of specific chemotherapy regimens (like Oxaliplatin, FOLFIRINOX, Paclitaxel alone or with Carboplatin) can join. It's not for those who need a treatment pause for surgery.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- The Lilac Device
Trial Overview
The trial is testing the Lilac Glove and Boot devices against sham devices to see if they can prevent moderate to severe peripheral neuropathy in hands and feet by reducing chemotherapy exposure to nerves during treatment.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Luminate Medical, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.